^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    ClearSEEK™ PIK3CA Panel

    Company:
    Agena Bio
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    The ClearSEEK™ PIK3CA Panel enables tumor profiling studies of breast cancer specimens. It detects 20 clinically relevant variants from PIK3CA. Identifies variants at as low as 1% variant allele frequency. Uses as little as 10 ng of DNA. Takes 1 hour of hands-on time and 8 hours of total time.
    Cancer:
    Breast Cancer
    Gene:
    PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)